XML 42 R2.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands
Sep. 30, 2011
Dec. 31, 2010
Current assets:  
Cash and cash equivalents$ 125,346$ 169,019
Investments3,4992,029
Accounts receivable48,99439,326
Inventories17,97912,722
Deferred tax assets, net7,2092,638
Income tax receivable, net24,4888,728
Restricted cash217217
Prepaid expenses and other current assets9,0338,814
Total current assets236,765243,493
Property, plant and equipment, net188,245152,701
In-process research and development51,40051,400
Goodwill5,5025,029
Assets held for sale12,06512,741
Deferred tax assets, net18,27833,757
Other assets7071,198
Total assets512,962500,319
Current liabilities:  
Accounts payable33,90225,409
Accrued expenses and other current liabilities1,1501,309
Accrued compensation14,73523,975
Contingent value rights, current portion9,8650
Long-term indebtedness, current portion4,92017,187
Deferred revenue, current portion4,3597,839
Total current liabilities68,93175,719
Contingent value rights, net of current portion5,99214,532
Long-term indebtedness, net of current portion48,87330,239
Deferred revenue, net of current portion2,7814,386
Other liabilities1,8821,882
Total liabilities128,459126,758
Commitments and contingencies00
Stockholders' equity:  
Preferred stock, $0.001 par value; 15,000,000 shares authorized, 0 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively00
Common stock, $0.001 par value; 100,000,000 shares authorized, 35,869,025 and 35,011,423 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively3635
Additional paid-in capital215,938197,689
Accumulated other comprehensive loss(2,894)(2,110)
Retained earnings168,212173,850
Total Emergent BioSolutions Inc. stockholders' equity381,292369,464
Noncontrolling interest in subsidiaries3,2114,097
Total stockholders' equity384,503373,561
Total liabilities and stockholders' equity$ 512,962$ 500,319